These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28885217)

  • 1. Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
    Shnier A; Lexchin J
    Int J Risk Saf Med; 2017; 29(1-2):1-16. PubMed ID: 28885217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
    Rothman DJ; McDonald WJ; Berkowitz CD; Chimonas SC; DeAngelis CD; Hale RW; Nissen SE; Osborn JE; Scully JH; Thomson GE; Wofsy D
    JAMA; 2009 Apr; 301(13):1367-72. PubMed ID: 19336712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an instrument to measure bias in CME.
    Takhar J; Dixon D; Donahue J; Marlow B; Campbell C; Silver I; Eadie J; Monette C; Rohan I; Sriharan A; Raymond K; Macnab J
    J Contin Educ Health Prof; 2007; 27(2):118-23. PubMed ID: 17576631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study.
    Yeh JS; Austad KE; Franklin JM; Chimonas S; Campbell EG; Avorn J; Kesselheim AS
    PLoS Med; 2014 Oct; 11(10):e1001743. PubMed ID: 25314155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Professional Medical Associations and Industry Guideline Compliance.
    Siegel M; Stedman A; Smith KA
    Pediatrics; 2015 Sep; 136(3):528-33. PubMed ID: 26240214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical industry-sponsored meetings: good value or just a free meal?
    Carney SL; Nair KR; Sales MA; Walsh J
    Intern Med J; 2001 Nov; 31(8):488-91. PubMed ID: 11720063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical education and communication companies: an updated in-depth profile.
    Golden GA; Parochka JN; Overstreet KM
    J Contin Educ Health Prof; 2002; 22(1):55-62. PubMed ID: 12004641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician-industry relations. Part 2: organizational issues.
    Coyle SL;
    Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Too few, too weak: conflict of interest policies at Canadian medical schools.
    Shnier A; Lexchin J; Mintzes B; Jutel A; Holloway K
    PLoS One; 2013; 8(7):e68633. PubMed ID: 23861928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.
    Kearney P; Simoons M; Ryden L; Kirchhof P; Pries A; O'Morain C; Bax JJ
    Am J Med; 2019 Aug; 132(8):921-925. PubMed ID: 30853472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sum of us: considerations on physician-industry relationships.
    Flores Rebollar A
    Medwave; 2017 May; 17(4):e6961. PubMed ID: 28582384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia.
    Lee YC; Kroon R; Koczwara B; Haines I; Francis K; Millward M; Kefford R; Olver I; Mileshkin L
    Intern Med J; 2017 Aug; 47(8):888-893. PubMed ID: 28485058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining quality criteria for online continuing medical education modules using modified nominal group technique.
    Shortt SE; Guillemette JM; Duncan AM; Kirby F
    J Contin Educ Health Prof; 2010; 30(4):246-50. PubMed ID: 21171030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.